Clinical trial
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
NCT00166452 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00166452 |
|---|---|
| Title | A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1 |
| Official title | Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1 |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Elgene Chemical Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Complex Regional Pain Syndrome, Type 1 |
| Intervention type | Drug |
| Interventions | Lenalidamide |
| Enrollment | 7 |
| Start date | Jul 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: